0
Skip to Content
Pharmacy Bridge
Legal Landscape
Data by State
Practice Model Types
Tell us about your practice!
Workflow Video
Legal & Educational Resources
Addiction Care Toolkits
Methadone Resources
Partners
Methodology
Team
News
Contact
Terms of Service
Privacy Policy
Interested in participating in research? Click here!
Pharmacy Bridge
Legal Landscape
Data by State
Practice Model Types
Tell us about your practice!
Workflow Video
Legal & Educational Resources
Addiction Care Toolkits
Methadone Resources
Partners
Methodology
Team
News
Contact
Terms of Service
Privacy Policy
Interested in participating in research? Click here!
Legal Landscape
Data by State
Folder: Practice Models
Back
Practice Model Types
Tell us about your practice!
Folder: Resources
Back
Workflow Video
Legal & Educational Resources
Addiction Care Toolkits
Methadone Resources
Folder: About
Back
Partners
Methodology
Team
News
Contact
Terms of Service
Privacy Policy
Interested in participating in research? Click here!

<< VIEW ALL QUESTIONS

  • Can a pharmacist independently order and evaluate lab tests (without a CPA)?
    Providing buprenorphine induction and maintenance services may include ordering and evaluating the results of lab tests. This question asks if a pharmacist can perform these functions as a matter of general practice without entering a CPA or protocol with a supervising physician or other healthcare provider.

    To answer this question, LAPPA reviewed the state’s definition of the practice of pharmacy and looked for additional laws and regulations expressly governing pharmacist authority. As compared to the question “Can a pharmacist administer buprenorphine without entering a CPA?”, pharmacy scope of practice laws/regulations more directly include or omit such authorization.

  • Can a pharmacist independently order and evaluate lab tests (without a CPA)?

    • Four states where the answer is “yes” as to lab tests in general; California, Colorado, Idaho, and Washington.

    • 29 states and the District of Columbia where the answer is “yes,” but only as to limited forms of tests that may not cover the types of tests necessary for patients undergoing treatment with buprenorphine. Typically, the provision allows a pharmacist to order CLIA-waived tests and/or tests related to specified illnesses/diseases that do not include OUD; Arkansas, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Iowa, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Vermont, Virginia, the District of Columbia, and Wyoming

    • One state where the authorization would cover only limited forms of tests, but it is unclear if the pharmacist can perform the tests; Alaska.

    • 16 states and Puerto Rico where the answer is “no.”; Alabama, Arizona, Indiana, Kansas, Kentucky, Louisiana, Maine, Mississippi, Missouri, Montana, Nebraska, Oklahoma, Texas, Utah, West Virginia, and Wisconsin. In these states the definition of the practice of pharmacy, as well as all other pharmacy laws/regulations, are silent with respect to lab tests.

    More details about each state’s laws and regulations can be found in the individual state charts.

Did we get something wrong? Click here to tell us about it!

DATA BY STATE

LEGAL LANDSCAPE

ABOUT

TEAM

TERMS OF SERVICE

RESEARCH

PARTNERS

CONTACT US

PRIVACY POLICY

Sign up to receive news and updates.

We value and respect your privacy.

Thank you!